Pfizer CEO Albert Bourla has pulled back the curtain on his $1.25 billion bet on a PD-1xVEGF bispecific, revealing that his ...

As President Donald Trump vows to bridge the drug pricing gap between the U.S. and other developed countries with his “most ...

Pfizer Inc. (NYSE:PFE) is one of the best wide moat stocks to buy now. On June 9, Pfizer, along with other drug manufacturers ...

CEO Albert Bourla has reportedly said that the company has made no commitments during its meeting with the Trump ...

Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...

Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no ...

Albert Bourla said Pfizer is being "frugal" with investments because of the uncertainty surrounding tariffs.

Some social media users claim another high-profile healthcare figure is also stepping down: Pfizer CEO Albert Bourla. "Pfizer CEO Albert Burla (sic) is stepping down and now says the mRNA ...

Talks with the Trump administration about lowering U.S. drug prices have so far not provided clarity on when and how reduced ...

When a novel coronavirus struck in early 2020, Pfizer’sPFE1.22%increase; green up pointing triangle chief executive, Dr. Albert Bourla, saw an opportunity to help save the world. He pushed the ...

STORY: Pfizer CEO Albert Bourla said Monday that he and other drug companies met with the Trump administration to discuss ...